Tenaya Therapeutics, Inc. (TNYA) Misses Q2 EPS by 14c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.20), $0.14 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.11 million versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• FTC escalates probe of Anthropic and OpenAI over consumer risks - NYP
• Leslie's files for chapter 11, closes 76 stores amid debt restructuring
• FactSet (FDS) Tops Q4 EPS by 17c, Beats on Revenue; Offers FY Guidance